TD Cowen analyst Charles Rhyee lowered the firm’s price target on Walgreens Boots Alliance to $22 from $35 and keeps a Buy rating on the shares. The price target update reflects Q3 results, revised FY24 guidance, and management’s FY25 commentary. While a turnaround will be challenging, the firm is encouraged by the actions management is taking, including accelerated store closures and reconfiguring the retail experience, and awaits further financial details in October, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Boots chief quitting as Walgreens’ sale plan stalls, Reuters reports
- Walgreens Boots Alliance price target lowered to $13 from $20 at Truist
- Walgreens Boots Alliance price target lowered to $10 from $17 at Evercore ISI
- Walgreens Boots Alliance price target lowered to $11 from $22 at BofA
- Walgreens Boots Alliance price target lowered to $9 from $13 at Morgan Stanley
